E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model

Molecular and Cellular Biology

Volumn 19, Issue 9, 1999, Pages 6408-6414

  Pierce, Angela M ^a   Schneider Broussard, Robin ^a   Gimenez Conti, Irma B ^a   Russell, Jamie L ^a   Conti, Claudio J ^a   Johnson, David G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; PROTEIN P53; TRANSCRIPTION FACTOR E2F;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM; FEMALE; FORESTOMACH; MALE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN; SKIN CARCINOMA; SKIN PAPILLOMA; TRANSGENIC MOUSE; VAGINA;

EID: 0032802177     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.9.6408     Document Type: Article

References (26)

1. ARF links the tumour suppressors RB and p53. Nature 395:124-125. (Letter.)
2. Bianchi, A. B., S. M. Fischer, A. I. Robles, E. M. Rinchik, and C. J. Conti. 1993. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 8:1127-1133.
3. Conti, C. J. 1994. The mouse skin as a model for chemical carcinogenesis, p. 39-46. In J. P. Sundberg (ed.), Handbook of mouse mutations with skin and hair abnormalities. CRC Press, Inc., Boca Raton, Fla.
4. DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245-7250.
5. Fueyo, J., C. Gomez-Manzano, W. K. A. Yung, T. J. Liu, R. Alemany, T. J. McDonnell, X. Shi, J. S. Rao, V. A. Levin, and A. P. Kyritsis. 1998. Over-expression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med. 4:685-690.
6. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
7. Hunt, K. K., J. Deng, T.-J. Liu, M. Wilson-Heiner, S. G. Swisher, G. Clayman, and M.-C. Hung. 1997. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 57:4722-4726.
8. Hupp, T. R., and D. P. Lane. 1995. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J. Biol. Chem. 270:18165-18174.
9. Johnson, D. G., D. Cress, L. Jakoi, and J. R. Nevins. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823-12827.
10. Kaufmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(S)K and PKB. Nature 385:544-548.
11. Leder, A., A. Kuo, R. D. Cardiff, E. Sinn, and P. Leder. 1990. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87:9178-9182.
12. Marquardt, B., D. Fritch, and S. Stabel. 1994. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9:3213-3218.
13. Pan, H., C. Yin, N. J. Dyson, E. Harlow, L. Yamasaki, and T. V. Dyke. 1998. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2:283-292.
14. L transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res. 58:2111-2116.
15. Pierce, A. M., S. M. Fischer, C. J. Conti, and D. G. Johnson. 1998. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16:1267-1276.
16. Pierce, A. M., I. B. Gimenez-Conti, R. Schneider-Broussard, L. A. Martinez, C. J. Conti, and D. G. Johnson. 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95:8858-8863.
17. Quintanilla, M., K. Brown, M. Ramsden, and A. Balmain. 1986. Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80.
18. Ramirez, A., A. Bravo, J. L. Jorcano, and M. Vida. 1994. Sequences 5′ of the bovine keratin 5 gene direct tissue-and-cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53-64.
19. Robles, A. I., and C. J. Conti. 1995. Early overexpression of cyclin D1 in mouse skin carcinogenesis. Carcinogenesis 16:781-786.
20. Rodriquez-Puebla, M. L., M. LaCava, I. B. Gimenez-Conti, D. J. Johnson, and C. J. Conti. 1998. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 17:2251-2258.
21. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
22. Singh, P., S. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329-3338.
23. Takenaka, I., F. Morin, B. R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270:5405-5411.
24. Xu, G., D. M. Livingston, and W. Krek. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357-1361.
25. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
26. Zhang, S.-Y., S.-C. Liu, T. Goodrow, R. Morris, and A. J. P. Klein-Szanto. 1997. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol. Carcinog. 18:142-152.